Longhitano, E.; Muscolino, P.; Lo Re, C.; Ferrara, S.A.; Cernaro, V.; Gembillo, G.; Tessitore, D.; Speranza, D.; Figura, F.; Santarpia, M.;
et al. Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine. Cancers 2023, 15, 1891.
https://doi.org/10.3390/cancers15061891
AMA Style
Longhitano E, Muscolino P, Lo Re C, Ferrara SA, Cernaro V, Gembillo G, Tessitore D, Speranza D, Figura F, Santarpia M,
et al. Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine. Cancers. 2023; 15(6):1891.
https://doi.org/10.3390/cancers15061891
Chicago/Turabian Style
Longhitano, Elisa, Paola Muscolino, Claudia Lo Re, Serena Ausilia Ferrara, Valeria Cernaro, Guido Gembillo, Dalila Tessitore, Desirèe Speranza, Francesco Figura, Mariacarmela Santarpia,
and et al. 2023. "Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine" Cancers 15, no. 6: 1891.
https://doi.org/10.3390/cancers15061891
APA Style
Longhitano, E., Muscolino, P., Lo Re, C., Ferrara, S. A., Cernaro, V., Gembillo, G., Tessitore, D., Speranza, D., Figura, F., Santarpia, M., Silvestris, N., Santoro, D., & Franchina, T.
(2023). Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine. Cancers, 15(6), 1891.
https://doi.org/10.3390/cancers15061891
